Joaquin Duato
Chairman & CEO of Johnson & Johnson (2022–Present)
Joaquin Duato has served as Chairman & CEO of Johnson & Johnson for 4 years 10 months (1,775 days), holding office continuously since Jan 3, 2022. At present, Joaquin Duato ranks as the #70 longest-serving chief executive among tracked leaders in the database.
Executive Succession & Corporate Facts
- Predecessor
- Not recorded
- Successor
- Active (Currently serving in office)
- Database Tenure Rank
- #70 Longest-Serving CEO in Database (View Full Rankings →)
- Company Founded
- Jan 1, 1886 (New Brunswick, New Jersey)
- Known Aliases
- Joaquín Duato Boix
Tenure Milestones & Transition Timeline
Joaquin Duato Appointed Next CEO of Johnson & Johnson Effective January 2022
J&J announced Chairman and CEO Alex Gorsky would transition to Executive Chairman for family health reasons, naming Joaquin Duato as successor.
Joaquin Duato Officially Takes Office as J&J CEO
Duato took office, directing pharmaceutical breakthroughs in oncology and immunology alongside medtech innovation.
J&J Reaches $16.6 Billion Agreement to Acquire Heart Recovery Firm Abiomed
Duato announced the acquisition of Abiomed, adding the Impella heart pump system to strengthen Johnson & Johnson MedTech.
Duato Completes Initial Public Offering and Spinoff of Kenvue
Duato oversaw the successful IPO of consumer health company Kenvue (Band-Aid, Tylenol), refocusing J&J as a pure-play pharma and medtech company.
Related Leaders & Rankings
Primary verified disclosure and leadership profile.
Compare tenure duration against currently active corporate leaders.
Compare against all 80 permanent executives in our database.